MEN2A is characterized by the presence of MTC combined with the development of pheochromocytoma and parathyroid hyperplasia/adenoma in ~50% and ~20% of affected family members, respectively. The gene discussed is RET; the disease is hereditary pheochromocytoma-paraganglioma.